Comparison of Ga-68-DOTATOC and F-18-FDG in patients with neuroendocrine tumors

被引：0
|
作者：
Koukouraki, S. [1 ]
Dimitrakopoulou-Strauss, A. [1 ]
Georgoulias, V. [2 ]
Schuhmacher, J. [1 ]
Haberkorn, U. [1 ]
Strauss, L. G. [1 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] Univ Crete, Dept Oncol, Iraklion, Crete, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [21] Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in clinical impact, management plan and prognosis in patients with Neuroendocrine Tumors
    Panagiotidis, Emmanouil
    Alshammari, Alshaima
    Michopoulou, Sofia
    Mohmaduvesh, Mullan
    Al-Harbi, Mohammed
    Skoura, Evangelia
    Berta, Maria
    Caplin, Martyn
    Toumpanakis, Christos
    Bomanji, Jamshed
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [22] Functional Imaging of Neuroendocrine Tumors: Comparison of PET/CT with 68Ga DOTATATE and 18FDG. Do we need 18FDG in neuroendocrine tumors?
    Kunikowska, J.
    Krolicki, L.
    Zemczak, A.
    Strzelczyk, J.
    Pawlak, D.
    Mikolajczak, R.
    Maczewska, J.
    Fronczewska-Wieniawska, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S272 - S272
  • [23] Comparison of 68Ga DOTATOC PET/CT with morphological imaging in staging of neuroendocrine tumors
    Finessi, M.
    Pilati, E.
    Passera, R.
    Liberini, V.
    De Angelis, C.
    Arvat, E.
    Birocco, N.
    Brizzi, M.
    Campra, D.
    Giraudo, G.
    Bello, M.
    Bisi, G.
    Deandreis, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S541 - S541
  • [24] Risk stratification in pancreatic neuroendocrine tumours: the role of combined 68Ga-DOTATOC and 18F-FDG PET/CT
    Mapelli, Paola
    Partelli, Stefano
    Salgarello, Matteo
    Muffatti, Francesca
    Rancoita, Paola Maria
    Pasetto, Stefano
    Gianolli, Luigi
    Falconi, Massimo
    Picchio, Maria
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [25] Dual tracer 68Ga-DOTATOC and 18F-FDG PET/CT for risk stratification in pancreatic neuroendocrine neoplasms
    Mapelli, P.
    Salgarello, M.
    Partelli, S.
    Muffatti, F.
    Pasetto, S.
    Rancoita, P.
    Gianolli, L.
    Falconi, M.
    Picchio, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S64 - S65
  • [26] What is the utility of combined 68Ga-DOTATOC and 18F-FDG- PET/CT in the work-up of subjects with neuroendocrine tumors of unknown origin?
    Bloise, I.
    Harsini, S.
    Benard, F.
    Wilson, D.
    Loree, J. M.
    Martineau, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S510 - S510
  • [27] Role of Ga68-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumors: Comparison with F18-FDG PET-CT and contrast enhanced CT
    Kumar, Rakesh
    Sharma, Punit
    Naswa, Niraj
    Sellam, Karunanithi
    Bal, Chandrasekhar
    Malhotra, Arun
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [28] The [ 68 Ga]Ga-DOTATATE and [ 18 F]FDG PET-CT imaging characteristics of metastatic neuroendocrine tumors
    Koc, Zehra Pinar
    Ozcan, Pinar Pelin
    Ercolak, Vehbi
    Kara, Tuba
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 32 (02): : 118 - 123
  • [29] Intracavernous Schwannoma Characterized With 18F-FDG, 68Ga-DOTATOC, and 18F-Choline PET
    Farce, Julien
    Lecouillard, Isabelle
    Carsin Nicol, Beatrice
    Bretonnier, Maxime
    Girard, Antoine
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : E165 - E166
  • [30] 68Ga-Labeled bombesin studies in patients with gastrointestinal stromal tumors:: Comparison with 18F-FDG
    Dimitrakopoulou-Strauss, Antonia
    Hohenberger, Peter
    Haberkorn, Uwe
    Maecke, Helmut R.
    Eisenhut, Michael
    Strauss, Ludwig G.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (08) : 1245 - 1250
12345